DD260494A5 - Verfahren zur herstellung von alpha-hydroxythiotherm - Google Patents
Verfahren zur herstellung von alpha-hydroxythiotherm Download PDFInfo
- Publication number
- DD260494A5 DD260494A5 DD86297075A DD29707586A DD260494A5 DD 260494 A5 DD260494 A5 DD 260494A5 DD 86297075 A DD86297075 A DD 86297075A DD 29707586 A DD29707586 A DD 29707586A DD 260494 A5 DD260494 A5 DD 260494A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- formula
- compound
- acid
- group
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH522885 | 1985-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD260494A5 true DD260494A5 (de) | 1988-09-28 |
Family
ID=4290092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86297075A DD260494A5 (de) | 1985-12-06 | 1986-12-04 | Verfahren zur herstellung von alpha-hydroxythiotherm |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4808572A (xx) |
| EP (1) | EP0225602B1 (xx) |
| JP (1) | JPS62138465A (xx) |
| AT (1) | ATE68177T1 (xx) |
| AU (1) | AU6613886A (xx) |
| CA (1) | CA1303294C (xx) |
| DD (1) | DD260494A5 (xx) |
| DE (1) | DE3681890D1 (xx) |
| DK (1) | DK586186A (xx) |
| ES (1) | ES2040205T3 (xx) |
| FI (1) | FI864901A (xx) |
| GR (1) | GR3003066T3 (xx) |
| HU (1) | HU196173B (xx) |
| IL (1) | IL80866A0 (xx) |
| NO (1) | NO864896L (xx) |
| PT (1) | PT83868B (xx) |
| ZA (1) | ZA869213B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149717A (en) * | 1988-03-29 | 1992-09-22 | Ciba-Geigy Corporation | Alkanophenones useful for treating allergies |
| FR2648814B1 (fr) * | 1989-06-26 | 1991-10-18 | Lafon Labor | L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique |
| EP0419410A3 (en) * | 1989-09-19 | 1991-08-14 | Ciba-Geigy Ag | Alkanophenones |
| DE59410387D1 (de) * | 1993-01-29 | 2004-10-21 | Ticona Gmbh | Faserverstärktes Cycloolefincopolymer-Material, Verfahren zu seiner Herstellung und Formkörper aus dem Material |
| WO2005047230A1 (en) * | 2003-11-13 | 2005-05-26 | The University Of Sydney | Bis-cationic compounds and use thereof |
| WO2007022718A1 (en) * | 2005-08-25 | 2007-03-01 | Chunde Liu | Alkyl aryl alkyl alcohols, their derivations and preparation process thereof |
| US8735627B2 (en) | 2010-10-28 | 2014-05-27 | Mapi Pharma Ltd. | Intermediate compounds and process for the preparation of fingolimod |
| CN102850319A (zh) * | 2011-06-27 | 2013-01-02 | 中国药科大学 | 一种制备{5-[2-(4-正辛基苯基)乙基]-2,2-二甲基-1,3-二氧六环-5-基}氨基甲酸叔丁酯的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE12241T1 (de) * | 1981-03-03 | 1985-04-15 | Lilly Industries Ltd | Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen. |
| US4513005A (en) * | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
| US4461775A (en) * | 1982-08-02 | 1984-07-24 | Mcneilab, Inc. | Hydroxythioether fatty acid derivatives |
| US4533747A (en) * | 1983-03-07 | 1985-08-06 | Smithkline Beckman Corporation | Leukotriene antagonists intermediates |
| DK130984A (da) * | 1983-03-07 | 1984-09-08 | Smithkline Beckman Corp | Leukotrien-antagonister |
| US4552893A (en) * | 1983-03-07 | 1985-11-12 | Smithkline Beckman Corporation | Leukotriene antagonists |
| EP0123543B1 (en) * | 1983-04-21 | 1988-02-03 | Merck Frosst Canada Inc. | Leukotriene antagonists, their production and use and compositions containing them |
| EP0170048B1 (de) * | 1984-06-28 | 1991-04-17 | Ciba-Geigy Ag | Aliphatische Thioether |
-
1986
- 1986-12-01 US US06/936,671 patent/US4808572A/en not_active Expired - Fee Related
- 1986-12-01 FI FI864901A patent/FI864901A/fi not_active IP Right Cessation
- 1986-12-03 ES ES198686116810T patent/ES2040205T3/es not_active Expired - Lifetime
- 1986-12-03 EP EP86116810A patent/EP0225602B1/de not_active Expired - Lifetime
- 1986-12-03 DE DE8686116810T patent/DE3681890D1/de not_active Expired - Lifetime
- 1986-12-03 AT AT86116810T patent/ATE68177T1/de active
- 1986-12-04 IL IL80866A patent/IL80866A0/xx unknown
- 1986-12-04 DD DD86297075A patent/DD260494A5/de unknown
- 1986-12-04 PT PT83868A patent/PT83868B/pt not_active IP Right Cessation
- 1986-12-04 CA CA000524509A patent/CA1303294C/en not_active Expired - Lifetime
- 1986-12-05 JP JP61289067A patent/JPS62138465A/ja active Pending
- 1986-12-05 HU HU865040A patent/HU196173B/hu not_active IP Right Cessation
- 1986-12-05 NO NO864896A patent/NO864896L/no unknown
- 1986-12-05 AU AU66138/86A patent/AU6613886A/en not_active Abandoned
- 1986-12-05 DK DK586186A patent/DK586186A/da not_active Application Discontinuation
- 1986-12-05 ZA ZA869213A patent/ZA869213B/xx unknown
-
1991
- 1991-11-06 GR GR91401392T patent/GR3003066T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI864901A (fi) | 1987-06-07 |
| DK586186D0 (da) | 1986-12-05 |
| NO864896L (no) | 1987-06-09 |
| DK586186A (da) | 1987-06-07 |
| DE3681890D1 (en) | 1991-11-14 |
| AU6613886A (en) | 1987-06-11 |
| PT83868A (en) | 1987-01-01 |
| EP0225602A3 (en) | 1989-06-14 |
| EP0225602A2 (de) | 1987-06-16 |
| IL80866A0 (en) | 1987-03-31 |
| NO864896D0 (no) | 1986-12-05 |
| US4808572A (en) | 1989-02-28 |
| HU196173B (en) | 1988-10-28 |
| ZA869213B (en) | 1987-07-29 |
| FI864901A0 (fi) | 1986-12-01 |
| JPS62138465A (ja) | 1987-06-22 |
| HUT43560A (en) | 1987-11-30 |
| ATE68177T1 (de) | 1991-10-15 |
| EP0225602B1 (de) | 1991-10-09 |
| GR3003066T3 (en) | 1993-02-17 |
| CA1303294C (en) | 1992-06-09 |
| ES2040205T3 (es) | 1993-10-16 |
| PT83868B (pt) | 1989-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0228045B1 (de) | Aromatische Thioether | |
| EP1694318B1 (de) | (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum | |
| US20090062372A1 (en) | Glycopyrronium Salts and Their Therapeutic Use | |
| PL154186B1 (en) | Method for manufacturing arylic derivatives of the hydroxamic acid | |
| EP0170048B1 (de) | Aliphatische Thioether | |
| EP0225602B1 (de) | Alpha-Hydroxythioether | |
| EP0029247B1 (de) | Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE3942729A1 (de) | Capsaicin-derivate | |
| EP0335315B1 (de) | Neue Alkanophenone | |
| EP0726265A1 (de) | Antineurodegenerativ wirksame 10-Aminoaliphatyl-dibenz- b,f oxepine | |
| EP0539329A1 (de) | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten | |
| DE202012011888U1 (de) | Kristallines Mehrkomponentensystem von Rosuvastatin-Calciumsalz und Vanillin | |
| EP0455596B1 (de) | Substituierte Indole | |
| DE3326164A1 (de) | Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DD295846A5 (de) | Verfahren zur herstellung weiterer neuer alkanophenone | |
| DE69410024T2 (de) | Knorpelschützende Arzneimittel | |
| DD243697A5 (de) | Aliphatische thioether | |
| DE68907329T2 (de) | Leukotrien-Antagonisten. | |
| DE69615845T2 (de) | Polycyclische alkaloid-derivate als nmda-rezeptor-antagonisten | |
| DD261149A5 (de) | Verfahren zur herstellung neuartiger unsymmetrischer thioehter | |
| DE69107274T2 (de) | Phenoxyessigsäure-Derivate, Verfahren zu ihrer Herstellung, und pharmazeutische Zusammensetzungen die sie enthalten. | |
| DD275865A5 (de) | Verfahren zur herstellung neuer cysteinderivate | |
| EP0419411A2 (de) | Zusätzliche weitere neue Alkanophenone | |
| DD283617A5 (de) | Verfahren zur herstellung neuer alkanophenone | |
| DE60205035T2 (de) | Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate |